Oramed Pharmaceuticals Ownership | Who Owns Oramed Pharmaceuticals?


OverviewForecastFinancialsChart

Oramed Pharmaceuticals Ownership Summary


Oramed Pharmaceuticals is owned by 15.79% institutional investors, 14.63% insiders, and 69.58% retail investors. Bml capital management is the largest institutional shareholder, holding 7.65% of ORMP shares. iShares Micro-Cap ETF is the top mutual fund, with 0.21% of its assets in Oramed Pharmaceuticals shares.

ORMP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockOramed Pharmaceuticals15.79%14.63%69.58%
SectorHealthcare Stocks 232.86%10.65%-143.51%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bml capital management3.17M7.65%$10.77M
Murchinson1.75M4.20%$4.62M
Boothbay fund management845.39K2.03%$2.23M
Rathbones group233.02K0.56%$664.10K
Bank of america corp /de/173.24K0.43%$445.23K
Dimensional fund advisors lp158.21K0.38%$537.74K
Ritholtz wealth management155.48K0.38%$528.63K
Renaissance147.50K0.35%$420.38K
Wells fargo & company/mn130.09K0.31%$343.43K
Hillsdale investment management97.30K0.23%$330.82K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management3.17M6.91%$10.77M
Murchinson1.75M0.59%$4.62M
Boothbay fund management845.39K0.03%$2.23M
Sage capital management17.98K0.03%$61.13K
Glass jacobson investment advisors10.54K0.01%$35.84K
Ritholtz wealth management155.48K0.01%$528.63K
Hillsdale investment management97.30K0.01%$330.82K
Rbf capital42.95K0.01%$113.38K
Xtx topco23.89K0.00%$63.06K
Kathmere capital management15.07K0.00%$51.24K

Top Buyers

HolderShares% AssetsChange
Ritholtz wealth management155.48K0.01%155.48K
Wells fargo & company/mn130.09K0.00%109.10K
Hillsdale investment management97.30K0.01%97.30K
Hrt financial lp46.09K0.00%46.09K
Bailard32.48K0.00%32.48K

Top Sellers

HolderShares% AssetsChange
Two sigma advisers, lp---213.00K
Bank of america corp /de/173.24K--113.81K
Peapod lane capital---84.78K
State street---66.45K
Two sigma investments, lp---64.42K

New Positions

HolderShares% AssetsChangeValue
Ritholtz wealth management155.48K0.01%155.48K$528.63K
Hillsdale investment management97.30K0.01%97.30K$330.82K
Hrt financial lp46.09K0.00%46.09K$131.00K
Bailard32.48K0.00%32.48K$110.42K
Xtx topco23.89K0.00%23.89K$63.06K

Sold Out

HolderChange
Citigroup-4.00
Innealta capital-13.00
Global retirement partners-100.00
Mather group, llc.-100.00
Qube research-107.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202535-25.53%6,592,201-28.42%153.24%14-12.50%6-25.00%
Sep 30, 202544-4.35%7,236,0761.46%175.70%1550.00%8-46.67%
Jun 30, 202548-11.11%7,251,754-6.69%174.91%11-42.11%15-16.67%
Mar 31, 202554-10.00%7,772,7871.30%195.40%21-8.70%16-5.88%
Dec 31, 202423-59.65%3,266,676-53.06%72.70%13-40.91%2-85.71%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Micro-Cap ETF83.14K0.21%-
SPDR® Portfolio Developed Wld ex-US ETF56.82K0.14%-
RBC Microcap Value I45.30K0.11%-40.00K
Dimensional US Core Equity 2 ETF36.54K0.09%-
Bailard Micrcap Value32.48K0.08%32.48K
Bailard Small Cap Value32.48K0.08%32.48K
Nationwide Bailard Sm Cp Val M32.48K0.08%32.48K
MTF TR TA-Growth29.23K0.07%-1.13K
Avantis US Small Cap Equity ETF28.16K0.07%-
Dimensional US Small Cap ETF26.90K0.07%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 03, 2023Mayer Arie-Buy$11.12K
Apr 04, 2023Mayer Arie-Buy$8.40K
Mar 16, 2023KIDRON NADAV President and CEOBuy$53.01K
Mar 14, 2023KIDRON NADAV President and CEOBuy$201.00K
Mar 14, 2023Kidron Miriam Chief Scientific OfficerSell$201.00K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--
2024 Q4--

ORMP Ownership FAQ


Who Owns Oramed Pharmaceuticals?

Oramed Pharmaceuticals shareholders are primarily institutional investors at 15.79%, followed by 14.63% insiders and 69.58% retail investors. The average institutional ownership in Oramed Pharmaceuticals's industry, Biotech Stocks , is 382.13%, which Oramed Pharmaceuticals falls below.

Who owns the most shares of Oramed Pharmaceuticals?

Oramed Pharmaceuticals’s largest shareholders are Bml capital management (3.17M shares, 7.65%), Murchinson (1.75M shares, 4.20%), and Boothbay fund management (845.39K shares, 2.03%). Together, they hold 13.87% of Oramed Pharmaceuticals’s total shares outstanding.

Does Blackrock own Oramed Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Oramed Pharmaceuticals.

Who is Oramed Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is Oramed Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 6.91% of its assets in 3.17M Oramed Pharmaceuticals shares, valued at 10.77M$.

Who is the top mutual fund holder of Oramed Pharmaceuticals shares?

iShares Micro-Cap ETF is the top mutual fund holder of Oramed Pharmaceuticals shares, with 0.21% of its total shares outstanding invested in 83.14K Oramed Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools